You May Also Like

The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)*
Cite
CITE Title : The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)* Personal Author(s) : Chen, Robert T.;Carbery, Baevin;Mac, Lisa;Chapman, Louisa E.;Condit, Richard C.;Excler, Jean-Louis;Gurwith, Marc;Hendry, Michael;Khan, Arifa S.;Khuri-Bulos, Najwa;Klug, Bettina;Robertson, Jim S.;Seligman, Stephen J.;Sheets, Rebecca;Williamson, Anna-Lise; Published Date : Oct 08 2014 Source : Vaccine. 33(1):73-75. URL : https://stacks.cdc.gov/view/cdc/34287
• File Format:
Copy Export
• RIS
[PDF - 80.67 KB]
Personal Author:
Chen, Robert T. ;
Carbery, Baevin
...
Oct 08 2014 | Vaccine. 33(1):73-75.
Description:
Recombinant viral vectors provide an effective means for heterologous antigen expression in vivo and thus represent promising platforms for developing...
File Type:
[PDF - 80.67 KB]
File Type:
[PDF - 80.67 KB]

Deprescribing Trials: A Focus on Adverse Drug Withdrawal Events
Cite
CITE Title : Deprescribing Trials: A Focus on Adverse Drug Withdrawal Events Personal Author(s) : Hanlon, Joseph T;Gray, Shelly L; Published Date : 9 2022;9-2022; Source : J Am Geriatr Soc. 70(9):2738-2741 URL : https://stacks.cdc.gov/view/cdc/121529
• File Format:
Copy Export
• RIS
[PDF - 53.27 KB]
Personal Author:
Hanlon, Joseph T ;
Gray, Shelly L
9 2022 | J Am Geriatr Soc. 70(9):2738-2741
No Description
Public Access Available on:
September 01, 2023
File Type:
[PDF - 53.27 KB]